Urcosimod stable in single-use ampoules for more than 21⁄2 years FDA requires drug to show long-term shelf stability for approval Daily administration to patients via ampoules can minimize risk of ...

Surgeons restored corneal surfaces in the injured eyes of 14 patients in a small clinical trial. Stem cells from each patient’s healthy eye were cultivated in a lab to grow healthy tissue that could ...

Eye injuries that damage the cornea are usually irreversible and cause blindness. But a new clinical trial has repaired this damage in patients thanks to a transplant of stem cells from their ...

Limbal stem cell insufficiency is characterized by conjunctivalization of the corneal surface. As IVCM is able to differentiate between corneal and conjunctival epithelium, it is especially useful ...

Sight-robbing injuries to the cornea can be repaired using a groundbreaking experimental stem cell treatment, a new study shows. The cornea -- the clear outermost layer of the eye -- can become ...

Novel stem cell therapy repairs 'irreversible' corneal damage in clinical trial Date: March 4, 2025 Source: Mass Eye and Ear Summary: Results from a phase 1/2 clinical trial of a novel stem cell ...

Background: Transepithelial photorefractive keratectomy using Smart Pulse Technology (SPT-TransPRK) is currently the leading method for superficial refractive surgery, offering advantages such as a ...

Please provide your email address to receive an email when new articles are posted on . Allogenic corneal inlays are highly biocompatible and easy to implant. They offer a simple, safe solution ...